Prevalencia e incidencia de dolor crónico con y sin características neuropáticas en pacientes con cáncer
DOI:
https://doi.org/10.33448/rsd-v13i11.46863Palabras clave:
Incidencia; Neoplasias; Dolor; Prevalencia.Resumen
Objetivos: Identificar la prevalencia e incidencia del dolor crónico con y sin características neuropáticas en pacientes con cáncer en hospitales públicos de São Luís, Maranhão. Metodología: Este es un estudio transversal. La muestra estuvo compuesta por pacientes diagnosticados con cáncer que ingresaron en las clínicas de dos hospitales de oncología de la red pública de salud de la ciudad de São Luís – MA. Se identificó la prevalencia e incidencia del dolor crónico en pacientes con cáncer y luego se describió el perfil sociodemográfico y clínico y se utilizaron cuestionarios validados en portugués para identificar la presencia del componente neuropático en el dolor. Resultados: La muestra final de este estudio fue de 1020 pacientes. La prevalencia de dolor crónico en pacientes con cáncer fue del 35,3%. De ellos, el 62,5% presentaba dolor neuropático. Además, la incidencia fue del 21,4%. Las personas con NDRC fueron, en su mayoría, mujeres de bajos ingresos, con menor nivel educativo, afrodescendientes, de zonas rurales y diagnosticadas con cáncer de mama y cáncer de cuello uterino, principalmente. Conclusión: Una gran proporción de pacientes diagnosticados con cáncer viven con dolor crónico, ya sea con o sin componente neuropático, afectando principalmente a mujeres de bajos ingresos y menor nivel educativo.
Citas
Beyaz, S. G., Ergönenç, J. Ş., Ergönenç, T., Sönmez, Ö. U., Erkorkmaz, Ü., & Altintoprak, F. (2016). Postmastectomy pain: A cross-sectional study of prevalence, pain characteristics, and effects on quality of life. Chinese Medical Journal (Engl), 129(1), 66-71.
Bhatnagar, S., Mishra, S., Roshni, S., Gogia, V., & Khanna, S. (2010). Neuropathic pain in cancer patients—Prevalence and management in a tertiary care anesthesia-run referral clinic based in urban India. Journal of Palliative Medicine, 13(7), 819-824.
Bouhassira, D., Luporsi, E., & Krakowski, I. (2017). Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer. Pain, 158(6), 1118-1125.
Baek, S. K., Shin, S. W., Koh, S. J., Kim, J. H., Kim, H. J., Shim, B. Y., Kang, S. Y., Bae, S. B., Yun, H. J., Sym, S. J., Han, H. S., & Gil, H. Y. (2021). Significance of descriptive symptoms and signs and clinical parameters as predictors of neuropathic cancer pain. PLOS One, 16(8), e0252781. https://doi.org/10.1371/journal.pone.0252781
Cherif, F., Zouari, H. G., Cherif, W., Hadded, M., Cheour, M., & Damak, R. (2020). Depression prevalence in neuropathic pain and its impact on the quality of life. Pain Research and Management, 2020, 7408508. https://doi.org/10.1155/2020/7408508
Dalal, S., & Bruera, E. (2012). Assessing cancer pain. Current Pain and Headache Reports, 16, 314-324.
Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa. Ed. Artes Médicas.
Fallon, M. T. (2013). Neuropathic pain in cancer. British Journal of Anaesthesia, 111(1), 105-111.
Fatiregun, O., Sowunmi, A. C., Habeebu, M., Okediji, P., Alabi, A., Fatiregun, O., Adeniji, A., Awofeso, O., & Adegboyega, B. (2019). Prevalence and correlates of unmet supportive needs of Nigerian patients with cancer. JCO Global Oncology, 5, 1-9.
Ferreira, A. D., et al. (2016). Prevalência de ansiedade e depressão em pacientes oncológicos e identificação de variáveis predisponentes. Revista Brasileira de Cancerologia, 62(4), 321-328.
Garg, R., & Bhatnagar, S. (2014). Neuropathic pain in cancer survivors. Pain Management, 4(4), 309-316.
Gieseler, F., Gaertner, L., Thaden, E., & Theobald, W. (2018). Cancer diagnosis: A trauma for patients and doctors alike. The Oncologist, 23(7), 752-754.
Grammatico, S., Cesini, L., & Petrucci, M. T. (2016). Managing treatment-related peripheral neuropathy in patients with multiple myeloma. Blood and Lymphatic Cancer: Targets and Therapy, 6, 37-47.
Haumann, J., Joosten, E. B. A., & van den Beuken-van Everdingen, M. H. J. (2017). Pain prevalence in cancer patients: Status quo or opportunities for improvement? Current Opinion in Supportive and Palliative Care, 11(2), 99-104.
van Hecke, O., et al. (2014). Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain, 155, 654-662.
Ilhan, E., Chee, E., Hush, J., & Moloney, N. (2017). The prevalence of neuropathic pain is high after treatment for breast cancer: A systematic review. Pain, 158(11), 2082-2091.
Instituto Nacional de Câncer (Brasil). (2022a). Câncer: Tipos de câncer. Rio de Janeiro: INCA. https://www.gov.br/inca/pt-br/assuntos/cancer/tipos.
Instituto Nacional de Câncer (Brasil). (2017). Câncer: Tipos de câncer. Rio de Janeiro: INCA. https://www.gov.br/inca/pt-br/assuntos/cancer/tipos.
International Association for the Study of Pain. (2022). Terminology. Washington, D.C., USA.
https://www.iasp-pain.org/resources/terminology/#neuropathic-pain.
International Association for the Study of Pain. (2022). https://www.iasp-pain.org/Advocacy/icd.aspx?ItemNumber=5354#neuropathicpain.
Jain, P. N., Chatterjee, A., Choudhary, A. H., & Sareen, R. (2009). Prevalence, etiology, and management of neuropathic pain in an Indian cancer hospital. Journal of Pain & Palliative Care Pharmacotherapy, 23(2), 114-119.
Jiang, J., et al. (2019). Effect of pregabalin on radiotherapy-related neuropathic pain in patients with head and neck cancer: A randomized controlled trial. Journal of Clinical Oncology, 37(2), 135-143.
Kohrt, B. A., Griffith, J. L., & Patel, V. (2018). Chronic pain and mental health: Integrated solutions for global problems. Pain, 159(Suppl 1), S85–S90.
Kolb, N. A., Smith, A. G., Singleton, J. R., Beck, S. L., Howard, D., Dittus, K., Karafiath, S., & Mooney, K. (2018). Chemotherapy-related neuropathic symptom management: A randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up. Supportive Care in Cancer, 26(5), 1607-1615.
Lee, S. C., & Wang, C. H. (2015). Undertreatment of cancer pain. Acta Anaesthesiologica Taiwanica, 53(2), 58-61.
Lewis, M. A., Zhao, F., Jones, D., Loprinzi, C. L., Brell, J., Weiss, M., & Fisch, M. J. (2015). Neuropathic symptoms and their risk factors in medical oncology outpatients with colorectal vs. breast, lung, or prostate cancer: Results from a prospective multicenter study. Journal of Pain and Symptom Management, 49(6), 1016-1024.
Lopes, C., et al. (2022). Prevalência e persistência de ansiedade e depressão ao longo de cinco anos desde o diagnóstico de câncer de mama: O estudo prospectivo NEON-BC. Oncologia Atual, 29(3), 2141-2153.
Lu, F., Song, L., Xie, T., Tian, J., Fan, Y., & Liu, H. (2017). Current status of malignant neuropathic pain in Chinese patients with cancer: Report of a hospital-based investigation of prevalence, etiology, assessment, and treatment. Pain Practice, 17(1), 88-98.
Luizaga, C. T. M., Jardim, B. C., Wünsch Filho, V., Eluf Neto, J., & Silva, G. A. E. (2023). Recent changes in trends of mortality from cervical cancer in Southeastern Brazil. Revista de Saúde Pública, 57, 25. https://doi.org/10.11606/s1518-8787.2023057000432
Mañas, A., Monroy, J. L., Ramos, A. A., Cano, C., López-Gómez, V., Masramón, X., Pérez, M., & TENOR Collaborative Study Group. (2011). Prevalence of neuropathic pain in radiotherapy oncology units. International Journal of Radiation Oncology Biology Physics, 81(2), 511–520. https://doi.org/10.1016/j.ijrobp.2010.11.033
Meira, K. C., Magnago, C., Mendonça, A. B., Duarte, S. F. S., de Freitas, P. H. O., Dos Santos, J., de Souza, D. L. B., & Simões, T. C. (2022). Inequalities in temporal effects on cervical cancer mortality in states in different geographic regions of Brazil: An ecological study. International Journal of Environmental Research and Public Health, 19(9), 5591. https://doi.org/10.3390/ijerph19095591
Mercadante, S. (2013). Cancer pain. Current Opinion in Supportive and Palliative Care, 7, 139–143. https://doi.org/10.1097/SPC.0b013e32835d34d1
Moloney, N. A., & Lenoir, D. (2023). Assessment of neuropathic pain following cancer treatment. Anatomical Record (Hoboken).
Morales, A., Lavanderos, S., Haase, J., & Riquelme, C. (2015). Dolor neuropático oncológico en Chile: Eficacia del programa alivio del dolor y cuidados paliativos por cáncer avanzado / Neuropathic cancer pain in Chile: Efficacy of the pain relief for advanced cancer and palliative care program. Dolor, 24(63), 10–16.
Oh, S. Y., Shin, S. W., Koh, S. J., Bae, S. B., Chang, H., Kim, J. H., Kim, H. J., Hong, Y. S., Park, K. U., Park, J., Lee, K. H., Lee, N. R., Lee, J. L., Jang, J. S., Hong, D. S., Lee, S. S., Baek, S. K., Choi, D. R., Chung, J., Oh, S. C., Han, H. S., Yun, H. J., Sym, S. J., Yoon, S. Y., Choi, I. S., Shim, B. Y., Kang, S. Y., Kim, S. R., & Kim, H. J. (2017). Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients. Supportive Care in Cancer, 25(12), 3759–3767. https://doi.org/10.1007/s00520-017-3941-0
Oosterling, A., te Boveldt, N., Verhagen, C., van der Graaf, W. T., Van Ham, M., Van der Drift, M., Vissers, K., & Engels, Y. (2016). Neuropathic pain components in patients with cancer: Prevalence, treatment, and interference with daily activities. Pain Practice, 16(4), 413–421. https://doi.org/10.1111/papr.12329
Pais-Ribeiro, J., et al. (2007). Estudo de validação de uma versão em português da Escala Hospitalar de Ansiedade e Depressão. Psicologia, Saúde & Medicina, 12(2), 225–237.
Pérez, C., Sánchez-Martínez, N., Ballesteros, A., Blanco, T., Collazo, A., González, F., & Villoria, J. (2015). Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study. European Journal of Pain, 19(6), 752–761. https://doi.org/10.1002/ejp.758
Pickering, G., Morel, V., Joly, D., Villatte, C., Roux, D., Dubray, C., & Pereira, B. (2014). Prevention of post-mastectomy neuropathic pain with memantine: Study protocol for a randomized controlled trial. Trials, 15, 331. https://doi.org/10.1186/1745-6215-15-331
Posso, I. D., Palmeira, C. C. A., & Vieira, E. B. M. (2016). Epidemiology of neuropathic pain. Revista Dor, 17(1), 11–14.
Poço Gonçalves, J., Veiga, D., & Araújo, A. (2021). Chronic pain, functionality and quality of life in cancer survivors. British Journal of Pain, 15(4), 401–410. https://doi.org/10.1177/20494637211037569
Portenoy, R. K., & Ahmed, E. (2018). Síndromes dolorosas do câncer. Clínicas de Hematologia/Oncologia, 32(3), 371–386.
Rapti, E., Damigos, D., Apostolara, P., Roka, V., Tzavara, C., & Lionis, C. (2019). Patients with chronic pain: Evaluating depression and their quality of life in a single center study in Greece. BMC Psychology, 7(1), 86. https://doi.org/10.1186/s40359-019-0356-4
Reis-Pina, P., Acharya, A., & Lawlor, P. G. (2018). Cancer pain with a neuropathic component: A cross-sectional study of its clinical characteristics, associated psychological distress, treatments, and predictors at referral to a cancer pain clinic. Journal of Pain and Symptom Management, 55(2), 297–306. https://doi.org/10.1016/j.jpainsymman.2017.09.003
Reis, N. V. S., Andrade, B. B., Guerra, M. R., Teixeira, M. T. B., Malta, D. C., & Passos, V. M. A. (2020). The Global Burden of Disease Study estimates of Brazil's cervical cancer burden. Annals of Global Health, 86(1), 56. https://doi.org/10.5334/aogh.2969
Roberto, A., et al. (2016). Prevalence of neuropathic pain in cancer patients: Pooled estimates from a systematic review of published literature and results from a survey conducted in 50 Italian palliative care centers. Journal of Pain and Symptom Management, 51(6), 1065–1073. https://doi.org/10.1016/j.jpainsymman.2016.02.027
Roos, D. E. (2015). Radiotherapy for neuropathic pain due to bone metastases. Annals of Palliative Medicine, 4(4), 220–224. https://doi.org/10.21037/apm.2015.09.08
Russo, M. M., & Sundaramurthi, T. (2019). An overview of cancer pain: Epidemiology and pathophysiology. Seminars in Oncology Nursing, 35(3), 223–228. https://doi.org/10.1016/j.soncn.2019.03.001
Saito, T., Tomitaka, E., Toya, R., Matsuyama, T., Ninomura, S., Watakabe, T., & Oya, N. (2018). A neuropathic pain component as a predictor of improvement in pain interference after radiotherapy for painful tumors: A secondary analysis of a prospective observational study. Clinical and Translational Radiation Oncology, 12, 34–39. https://doi.org/10.1016/j.ctro.2018.07.001
Salvetti, M. de G., Machado, C. S. P., Donato, S. C. T., & Silva, A. M. da. (2020). Prevalence of symptoms and quality of life of cancer patients. Revista Brasileira de Enfermagem, 73(2), e20180287. https://doi.org/10.1590/0034-7167-2018-0287
Santos, J. G., et al. (2010). Translation to Portuguese and validation of the Douleur Neuropathic 4 Questionnaire. The Journal of Pain, 11(5), 484–490. https://doi.org/10.1016/j.jpain.2009.05.004
Scholz, J., Finnerup, N. B., Attal, N., Aziz, Q., Baron, R., Bennett, M. I., Benoliel, R., Cohen, M., Cruccu, G., Davis, K. D., Evers, S., First, M., Giamberardino, M. A., Hansson, P., Kaasa, S., Korwisi, B., Kosek, E., Lavand'homme, P., Nicholas, M., Nurmikko, T., Perrot, S., Raja, S. N., Rice, A. S. C., Rowbotham, M. C., Schug, S., Simpson, D. M., Smith, B. H., Svensson, P., Vlaeyen, J. W. S., Wang, S. J., Barke, A., Rief, W., & Treede, R. D. (2019). The IASP classification of chronic pain for ICD-11: Chronic neuropathic pain. Pain, 160(1), 53–59. https://doi.org/10.1097/j.pain.0000000000001384
Schuster, M., Bayer, O., Heid, F., & Laufenberg-Feldmann, R. (2018). Opioid rotation in cancer pain treatment. Deutsches Ärzteblatt International, 115(9), 135–142. https://doi.org/10.3238/arztebl.2018.0135
Shaulov, A., Rodin, G., Popovic, G., Caraiscos, V. B., Le, L. W., Rydall, A., Schimmer, A. D., & Zimmermann, C. (2019). Pain in patients with newly diagnosed or relapsed acute leukemia. Supportive Care in Cancer, 27(8), 2789–2797. https://doi.org/10.1007/s00520-019-04838-6
Shrestha, A. D., Neupane, D., Vedsted, P., & Kallestrup, P. (2018). Cervical cancer prevalence, incidence, and mortality in low- and middle-income countries: A systematic review. Asian Pacific Journal of Cancer Prevention, 19(2), 319–324. https://doi.org/10.22034/APJCP.2018.19.2.319
Shkodra, M., Brunelli, C., Zecca, E., Formaglio, F., Bracchi, P., Lo Dico, S., Caputo, M., Kaasa, S., & Caraceni, A. (2021). Neuropathic pain: Clinical classification and assessment in patients with pain due to cancer. Pain, 162(3), 866–874. https://doi.org/10.1097/j.pain.0000000000002109
Singh, V. K., Shetty, Y. C., Salins, N., & Jain, P. (2020). Prescription pattern of drugs used for neuropathic pain and adherence to NeuPSIG guidelines in cancer. Indian Journal of Palliative Care, 26(1), 13–18. https://doi.org/10.4103/IJPC.IJPC_53_19
Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Global Health, 11(2), e197–e206. https://doi.org/10.1016/S2214-109X(23)00025-3
Smith, B. H., & Torrance, N. (2012). Epidemiology of neuropathic pain and its impact on quality of life. Current Pain and Headache Reports, 16(3), 191–198. https://doi.org/10.1007/s11916-012-0250-3
Snijders, R. A. H., Brom, L., Theunissen, M., & van den Beuken-van Everdingen, M. H. J. (2023). Update on prevalence of pain in patients with cancer 2022: A systematic literature review and meta-analysis. Cancers (Basel), 15(3), 591. https://doi.org/10.3390/cancers15030591
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Taylor, R. S. (2006). Epidemiology of refractory neuropathic pain. Pain Practice, 6(1), 22–26. https://doi.org/10.1111/j.1533-2500.2006.00006.x
Teixeira, M. J., et al. (2009). DOR: Princípios e práticas. Artmed.
Toassi, R. S. C. & Petry, P. C. (2021). Metodologia científica aplicada a área de saúde. Ed. UFRGS.
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006). The epidemiology of chronic pain of predominantly neuropathic origin: Results from a general population survey. Journal of Pain, 7(4), 281–289. https://doi.org/10.1016/j.jpain.2005.11.005
Ulas, S., Eyigor, S., & Caramat, I. (2018). Qualidade de vida e dor neuropática em pacientes com câncer hospitalizados: Uma análise comparativa de pacientes em enfermarias de cuidados paliativos versus aqueles em enfermarias gerais. Indian Journal of Palliative Care, 24(3), 325–329. https://doi.org/10.4103/IJPC.IJPC_118_17
Vale, D. B., Sauvaget, C., Muwonge, R., Ferlay, J., Zeferino, L. C., Murillo, R., & Sankaranarayanan, R. (2016). Disparities in time trends of cervical cancer mortality rates in Brazil. Cancer Causes & Control, 27(7), 889–896. https://doi.org/10.1007/s10552-016-0780-9
Vargas, A. C., Dell Agnolo, C., Melo, W. A., Pelloso, F. C., Santos, L. D., Carvalho, M. D. B., & Pelloso, S. M. (2020). Trends in cervical cancer mortality in Brazilian women who are screened and not screened. Asian Pacific Journal of Cancer Prevention, 21(1), 55–62. https://doi.org/10.31557/APJCP.2020.21.1.55
Vieira, E. B. M., Garcia, J. B., da Silva, A. A., Mualem Araújo, R. L., & Jansen, R. C. (2012). Prevalence, characteristics, and factors associated with chronic pain with and without neuropathic characteristics in São Luís, Brazil. Journal of Pain and Symptom Management, 44(2), 239–251. https://doi.org/10.1016/j.jpainsymman.2011.07.003
Virgen, C. G., Kelkar, N., Tran, A., Rosa, C. M., Cruz-Topete, D., Amatya, S., Cornett, E. M., Urits, I., Viswanath, O., & Kaye, A. D. (2022). Pharmacological management of cancer pain: Novel therapeutics. Biomedicine & Pharmacotherapy, 156, 113871. https://doi.org/10.1016/j.biopha.2022.113871
Yanaizumi, R., Nagamine, Y., Harada, S., Kojima, K., Tazawa, T., & Goto, T. (2021). Prevalence of neuropathic pain in terminally ill patients with cancer admitted to a general ward: A prospective observational study. Journal of International Medical Research, 49(1), 300060520987726. https://doi.org/10.1177/0305735620987726
Yang, S., Tan, W., Ma, X., Qi, L., & Wang, X. (2022). Worldwide productivity and research trend of publications concerning cancer-related neuropathic pain: A bibliometric study. Journal of Pain Research, 15, 2747–2759. https://doi.org/10.2147/JPR.S372975
Yoon, S. Y., & Oh, J. (2018). Neuropathic cancer pain: Prevalence, pathophysiology, and management. Korean Journal of Internal Medicine, 33(6), 1058–1069. https://doi.org/10.3904/kjim.2018.180
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Clara Cardoso Maia de Grammont; João Batista Santos Garcia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Los autores que publican en esta revista concuerdan con los siguientes términos:
1) Los autores mantienen los derechos de autor y conceden a la revista el derecho de primera publicación, con el trabajo simultáneamente licenciado bajo la Licencia Creative Commons Attribution que permite el compartir el trabajo con reconocimiento de la autoría y publicación inicial en esta revista.
2) Los autores tienen autorización para asumir contratos adicionales por separado, para distribución no exclusiva de la versión del trabajo publicada en esta revista (por ejemplo, publicar en repositorio institucional o como capítulo de libro), con reconocimiento de autoría y publicación inicial en esta revista.
3) Los autores tienen permiso y son estimulados a publicar y distribuir su trabajo en línea (por ejemplo, en repositorios institucionales o en su página personal) a cualquier punto antes o durante el proceso editorial, ya que esto puede generar cambios productivos, así como aumentar el impacto y la cita del trabajo publicado.
